Detailansicht

Wissensnetz

Person

Mirko Petrovic

Arzt

Name	Mirko Petrovic
Ort	Belgien
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Arzt (charakteristischer Beruf)
Beziehung	Universiteit Gent
Quelle	https://be.linkedin.com/in/mirko-petrovic-214b0623 (Stand: 12.01.2023)
Datensatztyp	Person
GND-Nummer	1277929653
Datensatz-ID	1277929653
Beteiligt an alle anzeigen A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial Applicability of STOPP/START prescribing criteria in integrated Swedish administrative health registries and a Swedish population-based cohort Socially Assistive Robots in Aged Care: Expectations of Older Adults with MCI in Assisted Living Facilities and Their Caregivers Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarms A European perspective on the challenges of healthcare for older adults Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people: the SENATOR trial Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study Authors’ response to points raised by Boland et al. regarding STOPP/START version 3 criteria Management of Type 2 Diabetes in Frail Older Adults Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review Treating Hypertension in Older Adults in Light of the Recent STEP Trial: Can We Implement the Findings in Geriatric Practice? Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People Sustainable fall prevention across Europe: challenges and opportunities Barriers and facilitators in using a Clinical Decision Support System for fall risk management for older people: a European survey Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials Ghent Older People’s Prescriptions Community Pharmacy Screening (GheOP3S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens—rationale and design Guidance for appropriate use of psychotropic drugs in older people August 2020 Interim EuGMS guidance to prepare European Long-Term Care Facilities for COVID-19 EuGMS 2019 Congress report: evidence-based medicine in geriatrics Association between number of medications and mortality in geriatric inpatients: a Danish nationwide register-based cohort study Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials Interest in meta-research in geriatric medicine: a survey of members of the European Geriatric Medicine Society Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic Review Start low, go slow, but look far: the case of geriatric medicine in Balkan countries Toward a geriatric approach to patients with advanced age and cardiovascular diseases: position statement of the EuGMS Special Interest Group on Cardiovascular Medicine Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort – Trial Protocol Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action Development and Application of the GheOP3S-Tool Addendum on Potentially Inappropriate Prescribing (PIP) of Renally Excreted Active Drugs (READs) in Older Adults with Polypharmacy The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Mirko Petrovic

A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial

Applicability of STOPP/START prescribing criteria in integrated Swedish administrative health registries and a Swedish population-based cohort

Socially Assistive Robots in Aged Care: Expectations of Older Adults with MCI in Assisted Living Facilities and Their Caregivers

Evaluation of methods measuring medication adherence in patients with polypharmacy: a longitudinal and patient perspective

Response to letter by Masse O et al. STOPP/START version 3: clinical pharmacists are raising alarms

A European perspective on the challenges of healthcare for older adults

Diabetes mellitus increases risk of adverse drug reactions and death in hospitalised older people: the SENATOR trial

Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis

Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study

Authors’ response to points raised by Boland et al. regarding STOPP/START version 3 criteria

Management of Type 2 Diabetes in Frail Older Adults

Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review

Treating Hypertension in Older Adults in Light of the Recent STEP Trial: Can We Implement the Findings in Geriatric Practice?

Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey

A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients

ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People

Sustainable fall prevention across Europe: challenges and opportunities

Barriers and facilitators in using a Clinical Decision Support System for fall risk management for older people: a European survey

Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance

Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study

Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

Ghent Older People’s Prescriptions Community Pharmacy Screening (GheOP3S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care

International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study

Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens—rationale and design

Guidance for appropriate use of psychotropic drugs in older people

August 2020 Interim EuGMS guidance to prepare European Long-Term Care Facilities for COVID-19

EuGMS 2019 Congress report: evidence-based medicine in geriatrics

Association between number of medications and mortality in geriatric inpatients: a Danish nationwide register-based cohort study

Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

Interest in meta-research in geriatric medicine: a survey of members of the European Geriatric Medicine Society

Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic Review

Start low, go slow, but look far: the case of geriatric medicine in Balkan countries

Toward a geriatric approach to patients with advanced age and cardiovascular diseases: position statement of the EuGMS Special Interest Group on Cardiovascular Medicine

Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative

The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort – Trial Protocol

Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action

Development and Application of the GheOP3S-Tool Addendum on Potentially Inappropriate Prescribing (PIP) of Renally Excreted Active Drugs (READs) in Older Adults with Polypharmacy

The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients